OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
April 15, 2014
A study investigated the influence and correlation of critical process parameters for the optimization of in-process curing.
The selection of excipients is important in generic formulations due to the impact it has on the risk and performance of generic drugs.
April 10, 2014
FDA develops an assay that could speed the release of pandemic influenza vaccines.
April 07, 2014
Dalton Pharma completes its $2.5 million expansion in Toronto for sterile and aseptic filling capabilities.
April 02, 2014
Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.
Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.
April 01, 2014
Catalent Pharma Solutions recently launched several new softgel product developments, all of which solve a delivery problem, while offering IP advantages to drug manufacturers.
March 26, 2014
Crystal Pharmatech selects Freeslate for its CM Protege PharmD System.
Pfizer intends to submit a biologics license application for its investigational Meningococcal B vaccine candidate, Bivalent rlp2086, to FDA by mid-2014.
March 20, 2014
Aesica has successfully completed the validation of its high capacity manufacturing facility in Queenborough, UK, for commercial production. The